Comparing Ibuprofen And Indomethacin For The Treatment Of The Patent Ductus Arteriosus in Very Premature Babies
Status:
Withdrawn
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the safety and efficacy of ibuprofen, compared with
indomethacin, in the treatment for the closure of the patent ductus arteriosus in premature
babies born under 29 weeks gestation
Phase:
Phase 4
Details
Lead Sponsor:
KK Women's and Children's Hospital
Collaborators:
Cumberland Pharmaceuticals National University Hospital, Singapore